Others have observed an increase in CD40L and also in calcineurin expression after ERα and ERβ agonist treatment of PBMCs from SLE patients [121], suggesting that defects in ER signal transduction may also contribute to SLE in both mice and humans. The gene discussed is ESR1; the disease is systemic lupus erythematosus.